Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 753

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 753
---
167 options
to purchase shares of common stock at a per share exercise price of $6.85 to Kristen Landon, our Chief Commercial Officer, which vest
in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024.

On January 2, 2025, we granted a total of 120,000
options to purchase shares of common stock at a per share exercise price of $6.55 to Geoff Dow, our Chief Executive Officer, (105,000
common stock options) and Tyrone Miller, our Chief Financial Officer (15,000 common stock options), which vest in five equal tranches.
The first tranche was fully vested on the date of grant and thereafter, the options vest on the last date of each fiscal year beginning
December 31, 2025.

Issuance
of Notes

On May 14, 2020, we issued the Note to the U.S.
Small Business Administration with a principal amount of $150,000 and a per annum interest rate of 3.75%.

On May 19, 2022, we issued the Convertible Promissory
Note to Geoffrey Dow, as assigned to the Geoffrey S. Dow Revocable Trust dated August 27, 2018 (the “Dow Note”), in the amount
of $44,444.44 and a per annum interest rate of 6%. Immediately prior to the closing of our initial public offering, the balance of the
Dow Note converted at a price equal to 80% of the IPO price.

On May 19, 2022, we issued the Mountjoy Note
in the amount of $294,444.42 and a per annum interest rate of 6%. Immediately prior to the closing of our initial public offering, the
balance of the Mountjoy Note converted at a price equal to 80% of the IPO price.

On May 24, 2022, we issued the Bigger Capital
Fund Note in the amount of $333,333.30 to Bigger Capital Fund, LP. On the date of the pricing of our initial public offering, we delivered
to Bigger Capital Fund, LP shares of our common stock equal to the number of shares of common stock calculated using a share price of
the IPO price.

On May 24, 2022, we issued the Cavalry Investment
Fund Note in the amount of $277,777.78 to